Dagmar Ehrnhoefer is a Principal Research Scientist II at AbbVie in Ludwigshafen, Germany, with over 17 years of experience in biochemistry, focusing on the molecular and cellular mechanisms of human disease. They lead a laboratory team dedicated to identifying therapeutic targets for Tau pathology in Alzheimer's disease. Previously, Dagmar served as a group leader at BioMed X GmbH, guiding research on tau-mediated neuropathology, and held a research associate role at The University of British Columbia, where they studied caspase-6 in Huntington's disease. Dagmar earned a PhD in Molecular Biology from Humboldt-Universität zu Berlin, graduating summa cum laude.
This person is not in the org chart
This person is not in any teams
This person is not in any offices